KaliVir Immunotherapeutics
Develops oncolytic immunotherapies for patients with advanced solid tumors
$14MSeries A
Role not disclosedSI
SV Investment
Activity from announced rounds
Activity in this selectionsimplyhealth-ventures-98030ada
- Rounds participated in
- 5
- Confirmed lead rounds
- — 5 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $271M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionLinqAlpha
Builds AI agents for institutional investors to surface market-moving signals in public markets
$22MSeries A
Role not disclosedCarbonSix
Develops deployment-ready robotic intelligence and automation solutions for manufacturing
$40MSeries A
Role not disclosedXCENA
Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research
$135MSeries B
Role not disclosedBreezeBio
Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
$60MSeries B
Role not disclosed